Strategic Acquisitions:
Boston Scientific's recent acquisitions, including Axonics, Relievant Medsystems, and partial offer for Acotec, signify its proactive expansion strategy, targeting new growth opportunities in medical segments and lucrative markets like China.
Innovative Product Introductions:
Introduction of innovative products strengthens Boston...
Hi,
please see the following chart pattern, that has been confirmed in the last weeks.
Accordingly to the rules of the pattern, the price target is about 70$.
If doesn't will come a market crash, there is a good opportunity, to reach the TP.
The price action is supported with the AI hype, that is easily possible, that we will become a news, that a company will...
I believe BSX had a good run up the past couple of weeks. And by looking at how its finding resistance at the top key levels, I expect to have a potential move down to $54 area. Again, risk management is key. Expected return vs risk is important. Always keep that in mind. The markets are choppy so you got to be careful on your entires. Ill give it til beginning of...
With a recent surge to record highs, fueled by positive developments and robust financial performance, here's a compelling case for potential buyers to consider adding NYSE:BSX stock to their portfolios.
1. Technical Analysis: Riding the Rising Trend Channel
Boston Scientific is currently riding a rising trend channel in the medium to long term, reflecting...
The high of October has been re-tested today. It serves as support now and is valid the more as is coincides with the 2 38% Fibonacci levels. A correction of the December decline seems to be likely.
Entry: when price clears 54.17
Volume: with daily volume greater than 7M
Target: 58 area
Stop: Depending on your risk tolerance; 52.91 gets you 3/1 Risk/Reward.
This swing trade idea is not trade advice and is strictly based on my ideas and technical analysis. No due diligence or fundamental analysis was performed while evaluating this trade idea. Do not take...
The PEAD projected a bullish outlook for NYSE:BSX after a positive over reaction following its earnings release placing the stock in drift B with an expected accuracy of 87.5%.
The PEAD projected a bullish outlook for NYSE:BSX after a positive over reaction following its earnings release placing the stock in drift B with an expected accuracy of 85.71%.
Boston Scientific develops, manufactures, and markets medical devices. Q4 earnings were reported this week providing a clear picture of 2022 annual fundamentals. The fundamentals considered are presented on the chart with brief commentary.
Technical considerations:
Price bounced off of trend line going back to 2012
Ascending triangle breakout
New ATH weekly...
Hey Everyone,
The market has been doing so crazy things the last year. Here is a company that seems to be handling market turmoil
well. BSX has recently retraced from the ATH of 47ish @ share. My personal view of BSX in the next couple of months are the following.
in the next 2 weeks I anticipate that BSX will retrace to the 43 @ share level. I judge this off...
The PEAD projected a Bullish outlook for $BSX after a Positive over reaction following its earnings release placing the stock in drift B with an expected accuracy of 83.33%.
The PEAD projected a Bullish outlook for $BSX after a Positive Under reaction following its earnings release placing the stock in drift A with an expected accuracy of 100%.
Areas in white rectangles show very similar price pattern and both lead to a should of the head and shoulders pattern present on the diagonal uptrend line
A larger double top can be observed between these two peaks
All these assumptions support a downward move on this Weekly timeframe
The PEAD projected a Bullish outlook for $BSX after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 66.67%.
Seems to be performing relatively well, just posting for future reference the C&H seems pretty blatant so interested how it will turn out. Mostly I just like the company.
